“…The rats were divided randomly into groups as described previously (Shi et al, 2018): control group (no infrasound exposure, n = 6), infrasound (IS) exposure groups (exposed to 16 Hz, 150 dB of infrasound for 1, 3, 5, or 7 days, n = 6 per group), FGF2 groups (treated with FGF2 for 1, 3, 5, or 7 days, n = 6 per group), PD groups (treated with PD173074 for 1, 3, 5, or 7 days, n = 6 per group), FGF2+IS groups (infrasound-exposed rats treated with FGF2, n = 6 per group), and PD + IS groups (infrasound-exposed rats treated with PD173074, n = 6 per group). For FGF2 administration, rats were injected intraperitoneally (i.p.)…”